LCGC North America
Metal-free columns should be considered when troubleshooting ion suppression. Chelating compounds that can form metal salt with stainless steel column housings are examined.
Most HPLC columns are made with stainless steel 316, which has surface oxides, and Fe(++), which have a high affinity for the exposed anionic oxygens present on phosphorylated compounds, and will readily interact causing adsorption and loss of sample. Additionally, these interactions can result in the formation of metal salts that can cause ion suppression when using LC–MS detection, potentially reducing analyte signal or, in extreme cases, cause no signal at all.
In this article, we show two cases of ion suppression and loss of sample due to adsorption, and recovery of signal strength by using our newly developed metal-free column housing. Our design utilizes the typical stainless-steel hardware so that we can preserve high-pressure capability, but the internal surfaces of the tubing and end fittings, as well as the inlet and outlet frits, are all coated with PEEK. This removes the largest contribution of metal surfaces within the HPLC sample flow path, significantly improving the analysis for certain compounds.
Figures 1 and 2 show organophosphorus pesticides or herbicides, and nucleoside triphosphates, respectively. All running conditions are shown within the figures. In each case, identical conditions were used on two columns packed with the same material; one with our metal-free housing, and the other with standard stainless steel.
The most dramatic example of ion suppression can be seen in Figure 1, particularly for glyphosate. While glufosinate does show signs of signal suppression and chelating, glyphosate is completely missing on the metal column, with LC–MS detection. Both peaks showed a much-improved LC–MS signal and analyte recovery when using a metal-free vs. a metal column. Peak shape was also improved.
Figure 1: Complete ion suppression of glyphosate signal
The triphosphates in Figure 2, while not completely missing as in the case of glyphosate, did show significant evidence of ion suppression and chelating for all nucleosides tested. In all cases, peak heights were dramatically reduced, and peak shape was negatively impacted. Under identical conditions, but in metal-free housing, all peaks showed an increase in symmetry and signal strength.
Figure 2: Triphosphates on metal-free vs. metal column
Often when troubleshooting issues with poor peak shape, low recovery and signal suppression, contributions of interaction with the column housing can easily be overlooked. Here we show that, particularly for certain compounds, there can be considerable interaction of the analytes with metal surfaces within the column. Therefore, the use of a metal-free column should be considered when troubleshooting issues related to poor peak shape, loss of sample, and ion suppression for potentially chelating compounds, especially when peak shape cannot be improved through modification of the mobile phase. It is also worth noting that we now offer metal-free columns in 15 different stationary phases, improving the range of available separation conditions. Please visit our website for more information.
Imtakt USA
2892 NW Upshur St., Portland, OR 97210
tel. (888) 456-HPLC, (215) 665-8902. Fax: (501) 646-3497
Website: ImtaktUSA.com
Free Poster: NDSRI Risk Assessment and Trace-Level Analysis of N-Nitrosamines
April 25th 2025With increasing concern over genotoxic nitrosamine contaminants, regulatory bodies like the FDA and EMA have introduced strict guidelines following several high-profile drug recalls. This poster showcases a case study where LGC and Waters developed a UPLC/MS/MS method for quantifying trace levels of N-nitroso-sertraline in sertraline using Waters mass spectrometry and LGC reference standards.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
Using the Carcinogenic Potency Categorisation Approach (CPCA) to Classify N-nitrosamine Impurities
April 25th 2025Learn how to manage nitrosamine impurities in pharmaceuticals with our free infographic. Discover how the CPCA approach establishes acceptable intake limits and guides the selection of NDSRI reference samples. Stay compliant and ensure safety with our ISO-accredited standards.